Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Copenhagen – page 41

778 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
778
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

778 trials in Copenhagen

Open in trial search

Neoplasm malignant

Not recruiting

Study on the Safety and Effectiveness of GEN1078 for Patients with Malignant Solid Tumors

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:GEN1078
  • Sponsor:Genmab A/S

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Adrenal insufficiency

Not recruiting

Study on Hydrocortisone for Stress in Patients with Polymyalgia Rheumatica or Giant Cell Arteritis and Adrenal Insufficiency

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:Rigshospitalet

Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Cardiac amyloidosis

Not recruiting

Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study on Stopping Mepolizumab or Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps After 12 Months Symptom-Free

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Rigshospitalet

Crohn's disease

Not recruiting

Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ORG-129
  • Sponsor:Agomab Spain S.L.U.

Study on the Effectiveness and Safety of Ropeginterferon and Bosutinib for Patients with Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:St. Olavs Hospital HF

Oesophageal carcinoma

Not recruiting

Study of trastuzumab with chemotherapy and immunotherapy combination for first-line treatment in patients with HER2-positive esophageal squamous cell cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Frederiksberg Hospital

Study of Nimorazole Treatment Based on Hypoxia Profile in Head and Neck Cancer Patients Receiving Radiotherapy with Cisplatin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Region Midtjylland

Asthma

Not recruiting

Study on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD8630
  • Sponsor:AstraZeneca AB

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.

  • Optimizing care for acute decompensated heart failure
  • Evaluating diuretic treatment strategies
  • Addressing risk of diuretic resistance

These trials support more effective day-to-day management of patients with unstable heart conditions.

02 Digestive System Diseases

Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.

  • Studying cirrhosis with ascites
  • Validating response markers for human albumin therapy
  • Improving personalized treatment decisions

This work may help refine care for people with advanced liver disease.

03 Neoplasms

Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.

  • Investigating colon cancer treatment response
  • Measuring clinical complete response
  • Supporting more tailored cancer care

These studies aim to strengthen precision treatment for selected colorectal cancer patients.

04 Nervous System Diseases

Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.

  • Focusing on emergency stroke management
  • Assessing early neurological improvement
  • Comparing current care with thrombolysis approaches

These trials are designed to support faster, more effective treatment decisions after stroke.

05 Virus Diseases

Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.

  • Studying hepatitis B infection
  • Testing new antibody-based therapy concepts
  • Supporting better long-term disease control

These trials reflect active interest in advancing antiviral research in Denmark.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.